Nu-Med Plus Inc (NUMD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nu-Med Plus Inc (NUMD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6558
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nu-Med Plus Inc (Nu-Med Plus) is a medical device company. The company offers medical products that deliver therapeutic doses of nitric oxide gas to patients. It provides nitric oxide gas delivery system, portable nitric oxide delivery system and nitric oxide dilution system. Nu-Med Plus’ nitric oxide is used for malaria, congenital pulmonary hypoplasia and neonatal hypoxia therapy. The company’s nitric oxide gas delivery system offers an intra-breath concentration of therapeutic nitric oxide to medically supervised patients on ventilators. It has developed inhaled nitric oxide products for use in hospital settings and for long-term applications. The company operates its laboratory in Orem, the US. Nu-Med Plus is headquartered in Salt Lake City, Utah, the US.

Nu-Med Plus Inc (NUMD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nu-Med Plus Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nu-Med Plus Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Nu-Med Plus Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nu-Med Plus Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Nu-Med Plus Raises US$0.12 Million In Venture Financing 10
Nu-Med Plus Raises US$0.09 Million In Venture Financing 11
Equity Offering 12
Nu-Med Plus Raises USD0.3 Million in Private Placement of Shares 12
Nu-Med Plus Inc – Key Competitors 13
Nu-Med Plus Inc – Key Employees 14
Nu-Med Plus Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Strategy And Business Planning 16
Jun 26, 2018: Nu-Med Plus Selects s2s Public Relations firm as its Strategic Partner 16
Corporate Communications 17
Feb 13, 2018: Nu-Med Plus Names Keith L. Merrell as full-time Chief Financial Officer and Secretary/Treasurer 17
Legal and Regulatory 18
Jul 31, 2018: Nu-Med Plus Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval 18
Product News 19
Aug 16, 2018: Nu-Med optimistic about nitric oxide prospects after patent ruling 19
Jun 05, 2018: Nu-Med Plus applies for Innovative Patent on Reactive Tube Coating 20
Other Significant Developments 21
Oct 09, 2018: Nu-Med Plus announces strategic rebrand to focus on leading advancements in the nitric oxide delivery industry 21
Aug 14, 2018: Nu-Med Plus Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market 22
Jun 12, 2018: Nu-Med Plus engages Millennium Biosciences for Quality and Regulatory consulting services 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Nu-Med Plus Inc, Medical Equipment, Key Facts, 2017 2
Nu-Med Plus Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nu-Med Plus Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nu-Med Plus Inc, Deals By Market, 2012 to YTD 2018 8
Nu-Med Plus Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nu-Med Plus Raises US$0.12 Million In Venture Financing 10
Nu-Med Plus Raises US$0.09 Million In Venture Financing 11
Nu-Med Plus Raises USD0.3 Million in Private Placement of Shares 12
Nu-Med Plus Inc, Key Competitors 13
Nu-Med Plus Inc, Key Employees 14
Nu-Med Plus Inc, Other Locations 15

List of Figures
Nu-Med Plus Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nu-Med Plus Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nu-Med Plus Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Nu-Med Plus Inc (NUMD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Navayuga Infotech Pvt. Ltd.:企業の戦略的SWOT分析
    Navayuga Infotech Pvt. Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Midland Power Cooperative:発電所・企業SWOT分析
    Midland Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Heidrick & Struggles International Inc (HSII):企業の財務・戦略的SWOT分析
    Summary Heidrick & Struggles International Inc (Heidrick & Struggles) is a provider of business advisory and consulting services. The company’s services comprise executive search, leadership consulting, and culture shaping services. Its leadership consulting services include leadership assessment an …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務情報
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Evoke Pharma Inc (EVOK):企業の財務・戦略的SWOT分析
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions fo …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • United Orthopedic Corp (4129)-医療機器分野:企業M&A・提携分析
    Summary United Orthopedic Corp (UOC) is a medical device company that designs, manufactures and distributes orthopedic implants and instrument sets. The company’s product categories include knee replacement systems, hip replacement systems, and oncology products. Its hip replacement systems include …
  • East Japan Railway Co:戦略・SWOT・企業財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kforce Inc. (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc. (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SgurrEnergy Ltd:企業の戦略的SWOT分析
    SgurrEnergy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes disco …
  • Harsco Corp:企業の戦略・SWOT・財務情報
    Harsco Corp - Strategy, SWOT and Corporate Finance Report Summary Harsco Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MitoGenetics LLC-製薬・医療分野:企業M&A・提携分析
    Summary MitoGenetics LLC (MitoGenetics) is a biomedical research and development company which produces proprietary compounds and intellectual property for the treatment of human, animal and plant diseases caused due to mitochondrial dysfunction. The company offers technology to regulate cellular mi …
  • PhaseBio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PhaseBio Pharmaceuticals Inc (PhaseBio) is a clinical-stage biopharmaceutical company that develops biotherapeutics for the treatment of orphan diseases and cardiopulmonary indications. The company offers ELP biopolymer technology, which includes PE0139 and PB1023 pipeline products. PhaseBio …
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Smith & Nephew Plc (SN.)-製薬・医療分野:企業M&A・提携分析
    Summary Smith & Nephew Plc (Smith & Nephew) develops, manufactures and markets medical devices for use in orthopedic reconstruction, orthopedic trauma and clinical therapies, sports medicines and advanced wound management. The company offers its products in various categories including Sports Medici …
  • Wirtgen GmbH:企業の戦略・SWOT・財務情報
    Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report Summary Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Spicers Ltd:企業の戦略的SWOT分析
    Spicers Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆